Boston Financial Mangement LLC grew its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) by 4.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 473,916 shares of the company’s stock after buying an additional 21,427 shares during the period. Boston Financial Mangement LLC owned approximately 0.18% of Ryan Specialty worth $30,406,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Alberta Investment Management Corp purchased a new stake in Ryan Specialty in the fourth quarter worth approximately $576,000. Truist Financial Corp boosted its stake in shares of Ryan Specialty by 7.2% in the 4th quarter. Truist Financial Corp now owns 5,688 shares of the company’s stock valued at $365,000 after purchasing an additional 381 shares in the last quarter. CIBC Asset Management Inc grew its holdings in shares of Ryan Specialty by 5.6% during the 4th quarter. CIBC Asset Management Inc now owns 3,674 shares of the company’s stock valued at $236,000 after purchasing an additional 196 shares during the last quarter. Sanctuary Advisors LLC raised its position in Ryan Specialty by 1.2% in the 4th quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company’s stock worth $1,045,000 after purchasing an additional 188 shares during the period. Finally, Principal Financial Group Inc. lifted its stake in Ryan Specialty by 115.2% in the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company’s stock worth $117,619,000 after purchasing an additional 981,505 shares during the last quarter. Institutional investors own 84.82% of the company’s stock.
Analysts Set New Price Targets
RYAN has been the topic of several analyst reports. Keefe, Bruyette & Woods decreased their price objective on Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a report on Friday, January 10th. Morgan Stanley started coverage on Ryan Specialty in a research note on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target on the stock. Barclays increased their price objective on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. Finally, Wells Fargo & Company decreased their target price on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating on the stock in a research note on Tuesday, January 14th. One analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $74.40.
Ryan Specialty Price Performance
RYAN stock opened at $69.38 on Thursday. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. Ryan Specialty Holdings, Inc. has a 1 year low of $45.55 and a 1 year high of $75.97. The firm has a 50-day moving average of $65.58 and a 200 day moving average of $67.25. The company has a market cap of $18.17 billion, a P/E ratio of 90.11, a PEG ratio of 1.21 and a beta of 0.72.
Insider Transactions at Ryan Specialty
In other news, Director Nicholas Dominic Cortezi sold 29,466 shares of the business’s stock in a transaction on Monday, January 13th. The shares were sold at an average price of $65.06, for a total transaction of $1,917,057.96. Following the sale, the director now owns 45,409 shares in the company, valued at approximately $2,954,309.54. The trade was a 39.35 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In the last quarter, insiders sold 316,451 shares of company stock valued at $20,907,793. Corporate insiders own 11.10% of the company’s stock.
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
See Also
- Five stocks we like better than Ryan Specialty
- What is Put Option Volume?
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- How to Profit From Value Investing
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.